These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9368408)

  • 41. Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar
    Rasamoelina T; Maubon D; Andrianarison M; Ranaivo I; Sendrasoa F; Rakotozandrindrainy N; Rakotomalala FA; Bailly S; Rakotonirina B; Andriantsimahavandy A; Rabenja FR; Andrianarivelo MR; Cornet M; Ramarozatovo LS
    Emerg Infect Dis; 2020 Jun; 26(6):1201-1211. PubMed ID: 32441639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromomycosis in Japan.
    Fukushiro R
    Int J Dermatol; 1983 May; 22(4):221-9. PubMed ID: 6345416
    [No Abstract]   [Full Text] [Related]  

  • 43. Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.
    Tan H; Xu Y; Lan XM; Wu YG; Zhou CJ; Yang XC
    Mycopathologia; 2015 Jun; 179(5-6):447-52. PubMed ID: 25575792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa.
    Arango M; Jaramillo C; Cortés A; Restrepo A
    Med Mycol; 1998 Feb; 36(1):43-5. PubMed ID: 9776811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chromoblastomycosis in Rio Grande do Sul: a report of 12 cases].
    Matte SM; Lopes JO; Melo IS; Espadim LE; Pinto MS
    Rev Soc Bras Med Trop; 1997; 30(4):309-11. PubMed ID: 9265226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Septic arthritis and osteomyelitis due to the chromoblastomycosis agent Fonsecaea pedrosoi.
    De Guzman L; Perlman DC; Hubbard CE
    Am J Orthop (Belle Mead NJ); 2012 Jul; 41(7):328-31. PubMed ID: 22893884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan.
    Tanuma H; Hiramatsu M; Mukai H; Abe M; Kume H; Nishiyama S; Katsuoka K
    Mycoses; 2000; 43(1-2):79-83. PubMed ID: 10838854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.
    Criado PR; Careta MF; Valente NY; Martins JE; Rivitti EA; Spina R; Belda W
    J Dermatolog Treat; 2011 Jun; 22(3):167-74. PubMed ID: 20666671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chromoblastomycosis caused by Phialophora verrucosa on the hand.
    Takeuchi A; Anzawa K; Mochizuki T; Takehara K; Hamaguchi Y
    Eur J Dermatol; 2015; 25(3):274-5. PubMed ID: 26066414
    [No Abstract]   [Full Text] [Related]  

  • 50. Chromoblastomycosis presenting as a phagedenic ulcer on the face.
    Naveen KN; Shetty PC; Naik AS; Pai VV; Hanumanthayya K; Udupishastry D
    Int J Dermatol; 2012 May; 51(5):576-8. PubMed ID: 21923692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.
    Santos AL; Palmeira VF; Rozental S; Kneipp LF; Nimrichter L; Alviano DS; Rodrigues ML; Alviano CS
    FEMS Microbiol Rev; 2007 Sep; 31(5):570-91. PubMed ID: 17645522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association.
    Antonello VS; Appel da Silva MC; Cambruzzi E; Kliemann DA; Santos BR; Queiroz-Telles F
    Rev Inst Med Trop Sao Paulo; 2010; 52(6):329-31. PubMed ID: 21225217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromoblastomycosis: clinical experience and review of literature.
    Queiróz AJR; Pereira Domingos F; Antônio JR
    Int J Dermatol; 2018 Nov; 57(11):1351-1355. PubMed ID: 30113072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Invasive chromoblastomycosis and sinusitis due to Phialophora verrucosa in a child from northern Africa.
    Hofmann H; Choi SM; Wilsmann-Theis D; Horré R; de Hoog GS; Bieber T
    Mycoses; 2005 Nov; 48(6):456-61. PubMed ID: 16262887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP; Li W; Huang WM; Zhou Y; Fan YM
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromoblastomycosis murine model and in vitro test to evaluate the sensitivity of Fonsecaea pedrosoi to ketoconazole, itraconazole and saperconazole.
    Cardona-Castro N; Agudelo-Flórez P; Restrepo-Molina R
    Mem Inst Oswaldo Cruz; 1996; 91(6):779-84. PubMed ID: 9283666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipases of Fonsecaea pedrosoi and Phialophora verrucosa.
    Okeke CN; Gugnani HC
    Antonie Van Leeuwenhoek; 1989 Apr; 55(4):313-24. PubMed ID: 2729958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
    J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod.
    Belda W; Criado PR; Passero LFD
    J Dermatol; 2020 Apr; 47(4):409-412. PubMed ID: 31960479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of chromoblastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine.
    Sevigny GM; Ramos-Caro FA
    Cutis; 2000 Jul; 66(1):45-6. PubMed ID: 10916691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.